Wpd Pharmaceuticals Stock Net Income
Fundamental analysis of WPD Pharmaceuticals allows traders to better anticipate movements in WPD Pharmaceuticals' stock price by examining its financial health and performance throughout various phases of its business cycle.
WPD |
WPD Pharmaceuticals Company Net Income Analysis
WPD Pharmaceuticals' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current WPD Pharmaceuticals Net Income | (7.52 M) |
Most of WPD Pharmaceuticals' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, WPD Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, WPD Pharmaceuticals reported net income of (7.52 Million). This is 102.2% lower than that of the Healthcare sector and 110.74% lower than that of the Biotechnology industry. The net income for all United States stocks is 101.32% higher than that of the company.
WPD Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses WPD Pharmaceuticals' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of WPD Pharmaceuticals could also be used in its relative valuation, which is a method of valuing WPD Pharmaceuticals by comparing valuation metrics of similar companies.WPD Pharmaceuticals is currently under evaluation in net income category among its peers.
WPD Fundamentals
| Return On Equity | -21.8 | |||
| Return On Asset | -1.29 | |||
| Current Valuation | (221 K) | |||
| Shares Outstanding | 113.44 M | |||
| Shares Owned By Insiders | 39.61 % | |||
| Price To Book | 107.84 X | |||
| Gross Profit | (107.72 K) | |||
| EBITDA | (6.03 M) | |||
| Net Income | (7.52 M) | |||
| Cash And Equivalents | 637.59 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 306.19 K | |||
| Debt To Equity | 2.15 % | |||
| Current Ratio | 0.40 X | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (1.38 M) | |||
| Earnings Per Share | (0.03) X | |||
| Number Of Employees | 19 | |||
| Beta | 1.09 | |||
| Market Capitalization | 18.94 K | |||
| Total Asset | 2.68 M | |||
| Z Score | -6.6 | |||
| Net Asset | 2.68 M |
About WPD Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze WPD Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of WPD Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of WPD Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in WPD Pink Sheet
WPD Pharmaceuticals financial ratios help investors to determine whether WPD Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WPD with respect to the benefits of owning WPD Pharmaceuticals security.